HCW Biologics Inc.
HCWB
$4.99
-$0.27-5.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.23M | 1.95M | 1.10M | 2.44M | 1.11M |
| Total Receivables | 74.80K | 32.20K | 30.70K | 21.60K | 87.50K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 297.80K | 222.20K | 210.70K | 295.50K | 256.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 119.80K | 77.60K | 250.30K | 141.00K | 443.30K |
| Total Current Assets | 1.72M | 2.28M | 1.59M | 2.90M | 1.89M |
|
|
|||||
| Total Current Assets | 1.72M | 2.28M | 1.59M | 2.90M | 1.89M |
| Net Property, Plant & Equipment | 20.77M | 20.88M | 22.50M | 22.64M | 22.76M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 28.50K | 28.50K | 28.50K | 28.50K | 28.50K |
| Total Assets | 27.34M | 24.52M | 25.45M | 28.91M | 26.29M |
|
|
|||||
| Total Accounts Payable | 11.79M | 13.14M | 18.97M | 19.35M | 19.73M |
| Total Accrued Expenses | 1.13M | 1.10M | 1.08M | 1.07M | 1.17M |
| Short-term Debt | 6.58M | 6.81M | 6.81M | 6.42M | 6.23M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 470.00K | 10.10K | -- | -- | -- |
| Total Other Current Liabilities | 470.00K | 10.10K | -- | -- | -- |
| Total Current Liabilities | 19.96M | 21.06M | 26.86M | 26.85M | 27.14M |
|
|
|||||
| Total Current Liabilities | 19.96M | 21.06M | 26.86M | 26.85M | 27.14M |
| Long-Term Debt | -- | -- | -- | 367.20K | 7.71M |
| Short-term Debt | 6.58M | 6.81M | 6.81M | 6.42M | 6.23M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.62M | 692.50K | 692.50K | 1.75M | -- |
| Total Liabilities | 21.58M | 21.76M | 27.55M | 28.96M | 34.85M |
|
|
|||||
| Common Stock & APIC | 110.81M | 111.28M | 107.13M | 104.63M | 94.19M |
| Retained Earnings | -105.04M | -108.52M | -109.24M | -104.68M | -102.75M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 5.76M | 2.76M | -2.11M | -52.00K | -8.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.76M | 2.76M | -2.11M | -52.00K | -8.56M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.76M | 2.76M | -2.11M | -52.00K | -8.56M |
|
|
|||||